Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors-Reference-Cited by-同舟云学术

Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors

Published:2002-06 Issue:6 Volume:13 Page:956-964
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Garaventa A.,Boni L.,Lo Piccolo M.S.,Tonini G.P.,Gambini C.,Mancini A.,Tonegatti L.,Carli M.,di Montezemolo L.C.,Di Cataldo A.,Casale F.,Mazzocco K.,Cecchetto G.,Rizzo A.,De Bernardi B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/6/956/587925/mdf165.pdf

Reference21 articles.

1. Neuroblastoma, its natural history and prognosis: a study of 487 cases;Kinnier Wilson;Br Med J,1974

2. Paediatric update: neuroblastoma;Castleberry;Eur J Cancer,1997

3. Neuroblastoma;Hayes,1993

4. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cis-retinoic acid;Matthay;N Engl J Med,1999

5. Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from Neuroblastoma Group of the Spanish Society of Pediatric Oncology;Castel;Med Pediatr Oncol,1995

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational intelligence analysis of high-risk neuroblastoma patient health records reveals time to maximum response as one of the most relevant factors for outcome prediction;European Journal of Cancer;2023-11

2. Postchemotherapy gross residual tumor in non‐high‐risk neuroblastoma: Clinical significance and the role of adjuvant therapy;Pediatric Blood & Cancer;2022-06-23

3. A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol;BMC Pediatrics;2020-05-12

4. Nuclear Medicine Procedures in Neuroblastoma;Neuroblastoma;2019-08-13

5. 131I-MIBG Therapy of Malignant Neuroblastoma and Pheochromocytoma;Nuclear Medicine Therapy;2019